{"id":535903,"date":"2021-09-08T16:13:18","date_gmt":"2021-09-08T20:13:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/"},"modified":"2021-09-08T16:13:18","modified_gmt":"2021-09-08T20:13:18","slug":"htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/","title":{"rendered":"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">TUCSON, Ariz., Sept.  08, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fR8Nnwd4LxDD9Az7g_eR8_tj4rIWp5ZUp45xJ9OaQJljGhlM1uxKoD_7si05uT2xuVn-3k_ax9p4_5wjPKubunvgWT_RFioZRiMm-tO3ogI=\" rel=\"nofollow noopener\" target=\"_blank\">HTG Molecular Diagnostics<\/a>, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright\u2019s 23rd Annual Global Investment Conference, being held September 13th \u2013 15th, 2021.<\/p>\n<p>Details for the presentation are below:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:9%;width:9%;min-width:9%;vertical-align: top;vertical-align: bottom\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"max-width:91%;width:91%;min-width:91%;vertical-align: top;vertical-align: bottom\">\n            <strong>7:00 a.m. ET<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;vertical-align: bottom\">\n            <strong>Time:<\/strong>\n          <\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\n            <strong>Monday, September 13th, 2021<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;vertical-align: bottom\">Webcast:<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\n            <a href=\"https:\/\/shared.outlook.inky.com\/link?domain=journey.ct.events&amp;t=eyJ0eXAiOiJKV1QiLCJhbGciOiJFUzI1NiJ9.eJxtkF1vgjAUhv9Lr0WwqBkmS8wyNRrBxDgRQmJKe5BiAdMW1C777wMvl92ej-c85_1GGkjJGZohwTNQlBPWclVLhQaIVxpkRQSaZUQoGCDoxy41E3BXVz7P9aWsBdBGEDmkddmt9KB_yo0Ur4a-qVliJ3ZRN7KC55DqIbRQaZXYLYd7YrvT0ch9cxzLmxBqjak3slLsEYtNgU4dcDLGso63-0KzqhFigHQugeiz6DDdCaeT7hXSlSjjU1CQcHllpTCpuzFbvDQkPD4jnN9S50ORMBYUB7co3GNyClpa-U2EPb01_iQ4fD18s8_jYpPHq1gE-FjEYfTcHdajIFy4u9DH8Scdb80C-2Zx983l4RfrJjDRe_-uAnmGknBxJoxJUKpzIoqDpDmv53-SfmX08wt5s4b8.MEUCIQDjBxR7CCOChfY4s9clRt1rPbsDmCog-eoN310KQUdyXAIgM6KH0nSqutUeXXehq-3J4m-4NpME5M8jGZRr38SPwcY\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journey.ct.events\/view\/36113800-95ac-4c91-b29a-d6ec60e0fddf<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>Management will also be available for 1&#215;1 meetings. If you would like to request a meeting, please email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GDAwA4rOKrhbMonmRyymQMnT_iZLyxOcqo4IcVxwjxUf49KLErr_dVguT0bp3zIziLKFy1uckwsNEcn61oIwjGGRTJLXVvgOlxhjBYF0FZU=\" rel=\"nofollow noopener\" target=\"_blank\">meetings@hcwco.com<\/a>.<\/p>\n<p>\n        <strong>About HTG:<\/strong><br \/>\n        <br \/>HTG is focused on NGS-based molecular profiling. The company\u2019s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower precision medicine. To learn more, visit www.htgmolecular.com.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Ashley Robinson<br \/>Phone: (617) 430-7577<br \/>Email: arr@lifesciadvisors.com\u00a0<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YzI5ZmIzNGQtODFhOS00ZTc0LWExNmYtMDk4NjExMTJhMmFjLTEwMjg0NTI=\/tiny\/HTG-Molecular-Diagnostics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright\u2019s 23rd Annual Global Investment Conference, being held September 13th \u2013 15th, 2021. Details for the presentation are below: Date: 7:00 a.m. ET Time: Monday, September 13th, 2021 Webcast: https:\/\/journey.ct.events\/view\/36113800-95ac-4c91-b29a-d6ec60e0fddf Management will also be available for 1&#215;1 meetings. If you would like to request a meeting, please email meetings@hcwco.com. About HTG: HTG is focused on NGS-based molecular profiling. The company\u2019s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535903","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright\u2019s 23rd Annual Global Investment Conference, being held September 13th \u2013 15th, 2021. Details for the presentation are below: Date: 7:00 a.m. ET Time: Monday, September 13th, 2021 Webcast: https:\/\/journey.ct.events\/view\/36113800-95ac-4c91-b29a-d6ec60e0fddf Management will also be available for 1&#215;1 meetings. If you would like to request a meeting, please email meetings@hcwco.com. About HTG: HTG is focused on NGS-based molecular profiling. The company\u2019s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower &hellip; Continue reading &quot;HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T20:13:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference\",\"datePublished\":\"2021-09-08T20:13:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/\"},\"wordCount\":164,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/\",\"name\":\"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=\",\"datePublished\":\"2021-09-08T20:13:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference - Market Newsdesk","og_description":"TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright\u2019s 23rd Annual Global Investment Conference, being held September 13th \u2013 15th, 2021. Details for the presentation are below: Date: 7:00 a.m. ET Time: Monday, September 13th, 2021 Webcast: https:\/\/journey.ct.events\/view\/36113800-95ac-4c91-b29a-d6ec60e0fddf Management will also be available for 1&#215;1 meetings. If you would like to request a meeting, please email meetings@hcwco.com. About HTG: HTG is focused on NGS-based molecular profiling. The company\u2019s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower &hellip; Continue reading \"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-08T20:13:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference","datePublished":"2021-09-08T20:13:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/"},"wordCount":164,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/","name":"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=","datePublished":"2021-09-08T20:13:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjM3NSM0Mzk1MTY0IzIwMTY4Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/htg-molecular-diagnostics-to-present-at-h-c-wainwrights-23rd-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HTG Molecular Diagnostics to Present at H.C. Wainwright\u2019s 23rd Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535903"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535903\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}